TY - JOUR
T1 - Kidney exchange match rates in a large multicenter clearinghouse
AU - Holscher, Courtenay M.
AU - Jackson, Kyle
AU - Chow, Eric K.H.
AU - Thomas, Alvin G.
AU - Haugen, Christine E.
AU - DiBrito, Sandra R.
AU - Purcell, Carlin
AU - Ronin, Matthew
AU - Waterman, Amy D.
AU - Garonzik, Jacqueline
AU - Massie, Allan B
AU - Gentry, Sommer Elizabeth
AU - Segev, Dorry
N1 - Funding Information:
The interpretation and reporting of these data are the responsibility of the authors and in no way should be seen as an official policy of or interpretation by the US Government. Funding for this study was provided in part by the National Institute of Diabetes and Digestive and Kidney Disease (NIDDK), the National Institute on Aging, the American College of Surgeons, and the National Kidney Registry (NKR). This study was supported by grants number F32DK109662 (PI: Holscher), F32DK113719 (PI: Jackson), F32AG053025 (PI: Haugen), F32DK405600 (PI: DiBrito), K01DK101677 (PI: Massie), R01DK098431 (PI: Segev), and K24DK101828 (PI: Segev). Dr. Holscher is supported by the American College of Surgeons Resident Research Scholarship.
Funding Information:
The interpretation and reporting of these data are the responsibility of the authors and in no way should be seen as an official policy of or interpretation by the US Government. Funding for this study was provided in part by the National Institute of Diabetes and Digestive and Kidney Disease (NIDDK), the National Institute on Aging, the American College of Surgeons, and the National Kidney Registry (NKR). This study was supported by grants number F32DK109662 (PI: Holscher), F32DK113719 (PI: Jackson), F32AG053025 (PI: Haugen), F32DK405600 (PI: DiBrito), K01DK101677 (PI: Massie), R01DK098431 (PI: Segev), and K24DK101828 (PI: Segev). Dr.?Holscher is supported by the American College of Surgeons Resident Research Scholarship.
Publisher Copyright:
© 2018 The American Society of Transplantation and the American Society of Transplant Surgeons
PY - 2018/6
Y1 - 2018/6
N2 - Kidney paired donation (KPD) can facilitate living donor transplantation for candidates with an incompatible donor, but requires waiting for a match while experiencing the morbidity of dialysis. The balance between waiting for KPD vs desensitization or deceased donor transplantation relies on the ability to estimate KPD wait times. We studied donor/candidate pairs in the National Kidney Registry (NKR), a large multicenter KPD clearinghouse, between October 2011 and September 2015 using a competing-risk framework. Among 1894 candidates, 52% were male, median age was 50 years, 66% were white, 59% had blood type O, 42% had panel reactive antibody (PRA)>80, and 50% obtained KPD through NKR. Median times to KPD ranged from 2 months for candidates with ABO-A and PRA 0, to over a year for candidates with ABO-O or PRA 98+. Candidates with PRA 80-97 and 98+ were 23% (95% confidence interval, 6%-37%) and 83% (78%-87%) less likely to be matched than PRA 0 candidates. ABO-O candidates were 67% (61%-73%) less likely to be matched than ABO-A candidates. Candidates with ABO-B or ABO-O donors were 31% (10%-56%) and 118% (82%-162%) more likely to match than those with ABO-A donors. Providers should counsel candidates about realistic, individualized expectations for KPD, especially in the context of their alternative treatment options.
AB - Kidney paired donation (KPD) can facilitate living donor transplantation for candidates with an incompatible donor, but requires waiting for a match while experiencing the morbidity of dialysis. The balance between waiting for KPD vs desensitization or deceased donor transplantation relies on the ability to estimate KPD wait times. We studied donor/candidate pairs in the National Kidney Registry (NKR), a large multicenter KPD clearinghouse, between October 2011 and September 2015 using a competing-risk framework. Among 1894 candidates, 52% were male, median age was 50 years, 66% were white, 59% had blood type O, 42% had panel reactive antibody (PRA)>80, and 50% obtained KPD through NKR. Median times to KPD ranged from 2 months for candidates with ABO-A and PRA 0, to over a year for candidates with ABO-O or PRA 98+. Candidates with PRA 80-97 and 98+ were 23% (95% confidence interval, 6%-37%) and 83% (78%-87%) less likely to be matched than PRA 0 candidates. ABO-O candidates were 67% (61%-73%) less likely to be matched than ABO-A candidates. Candidates with ABO-B or ABO-O donors were 31% (10%-56%) and 118% (82%-162%) more likely to match than those with ABO-A donors. Providers should counsel candidates about realistic, individualized expectations for KPD, especially in the context of their alternative treatment options.
KW - ABO incompatibility
KW - clinical research/practice
KW - donors and donation
KW - donors and donation: paired exchange
KW - health services and outcomes research
KW - kidney transplantation/nephrology
KW - kidney transplantation: living donor
KW - panel reactive antibody (PRA)
UR - http://www.scopus.com/inward/record.url?scp=85043463460&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85043463460&partnerID=8YFLogxK
U2 - 10.1111/ajt.14689
DO - 10.1111/ajt.14689
M3 - Article
C2 - 29437286
AN - SCOPUS:85043463460
SN - 1600-6135
VL - 18
SP - 1510
EP - 1517
JO - American Journal of Transplantation
JF - American Journal of Transplantation
IS - 6
ER -